STAT+: As monkeypox spreads, Bavarian Nordic’s CEO is fielding calls for his vaccine, but doesn’t see panic
As monkeypox threatens to become the latest global health concern, Bavarian Nordic has suddenly become…
Category: STAT+
STAT+: Flagship’s latest startup launches with bold claim: the discovery of thousands of new human proteins
A Cambridge, Mass., biotech company claims to have made a discovery that could rewrite biology…
STAT+: Pharmalittle: Teva and Allergan reach $161 million opioid settlement with West Virginia; FDA lifts hold on Bharat Covid shot
Hello, everyone, and how are you today? A steely gray sky is hovering this morning…
Opinion: STAT+: QR codes can help pharmaceutical companies in two big ways
QR codes, which had begun a fall into obscurity, have come roaring back. Many restaurants…
STAT+: There may be a backdoor way for hospitals to get paid for uninsured Covid-19 care
WASHINGTON — The federal health department shut down a program that paid hospitals and clinics…
STAT+: Proton cancer centers continue to proliferate, despite shaky benefits and checkered financiers
On May 12, the South Florida Proton Therapy Institute issued a warning to its investors:…
.jpg)
STAT+: ‘We have to test’: A Google AI leader on why it’s imperative to move slow in health tech
Google has big ideas for machine learning in medicine. Greg Corrado, who helps lead health…
STAT+: New kind of off-the-shelf cancer vaccine reduces metastasis in animal experiments
About 15 years ago, cancer researchers noticed a trend. Some of the patients they were…
STAT+: Pharmalittle: Pfizer to sell medicines and vaccines to poor countries at low prices; Germany orders vaccine to combat monkeypox
Hello, everyone, and how are you this fine, sunny morning? Birds are chirping and cool…
STAT+: Employers sue Advocate Aurora Health over alleged anticompetitive hospital contracts
An employer in Wisconsin has filed a class-action lawsuit against Advocate Aurora Health, alleging the…
STAT+: Pharmalittle: Is the Covid-19 gold rush over for drugmakers? Monkeypox attracts interest from vaccine makers
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
Opinion: STAT+: A market failure is preventing efficient diffusion of health care AI software
Artificial intelligence (AI) software can improve patient care, but a key market failure is preventing…
STAT+: The FDA says it’s in the dark about thousands of dietary supplement ingredients
WASHINGTON — The companies that make dietary supplements like vitamins and herbs have quietly introduced…
STAT+: Pharmalittle: Pfizer and BioNTech seek Covid-vaccine use in kids under 5; Pfizer refunds $290,000 over misleading coupons
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: How a complex web of businesses turned private health records from GE into a lucrative portrait of patients
It was supposed to be a routine client meeting. Instead, one of GE Healthcare’s largest…
STAT+: European regulator suspends generic drugs after finding flawed studies
In the latest dust-up over the safety of medicines, the European Medicines Agency recommended suspending…
STAT+: ‘No real clear path’: Insurance coverage for cutting-edge diagnostics remains a major challenge for personalized medicine
DANA POINT, Calif. — Even the best treatment for a disease is no help if…
STAT+: Pharmalittle: Cancer coalition aims to boost access to meds in poor countries; Moderna’s vaccine patent defense poses shield for others
And so, another working week will soon draw to a close. This is, as you…
STAT+: Pharmalittle: Pfizer resists requests for study supplies of its Covid pill; WTO talks on Covid vaccine patent waivers are bogged down
Good morning, everyone, and how are you today? The skies over the Pharmalot campus are…
STAT+: AbbVie dramatically boosts its spending on lobbying
WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three…
STAT+: Former top Medicare official says Medicare Advantage’s coding industry offers ‘no benefit to society’
Parts of the Medicare Advantage program — essentially, private Medicare plan options — are ripe…
STAT+: Pharmalittle: Moderna chair defends executive hiring process; analysis finds monopoly tactics preserve inhaler revenues
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: Drugmakers use monopoly tactics to thwart lower-cost generic competition for inhalers, analysis finds
For more than three decades, drugmakers have used various tactics to win and extend monopolies…
.jpg)
STAT+: High blood pressure pills are costly — but also hard to find — in some lower-income countries
A clutch of serious challenges — high prices, a lack of effective combination pills, and…
STAT+: Pharmalittle: FDA declines to approve old antidepressant for Covid; U.S.-China trade fight may derail WTO Covid patent waiver
Rise and shine, another busy day is on the way. However, this is also shaping…
STAT+: Two dozen states side with HHS in its raucous dispute with pharma over a drug discount program
Two dozen states have waded into the heated dispute between the U.S. government and a…
STAT+: Google taps FDA’s former digital health chief for global strategy role
Google has hired the former head of digital health at the U.S. Food and Drug…
STAT+: Apollo acquires minority stake in Sofinnova, extending private equity dealmaking in life sciences
Private equity giant Apollo Global Management is spending $1 billion for a piece of one…
STAT+: Greece plans to go to court to seek compensation from Novartis over a bribery scandal
The Greek health ministry plans to seek compensation from Novartis over a long-running bribery scandal…
STAT+: Seagen CEO resigns after arrest on domestic assault charges
Clay Siegall, co-founder and CEO of Seagen, has resigned in the wake of his arrest…
STAT+: Pharmalittle: Aspen may close South Africa Covid vaccine plant due to lack of orders; Roche insists it can overcome latest setback
And so, another working week will soon draw to a close. Not a moment too…
STAT+: 3 burning questions about the future of prescribing drugs online
Online companies prescribing and dispensing medications like Adderall are garnering increasing scrutiny from clinicians and…
STAT+: National Institutes of Health licenses nearly a dozen Covid-19 technologies to a WHO program
In a notable bid to widen global access to Covid-19 medical products, the National Institutes…
STAT+: Arkansas becomes the latest state to sue drugmakers and PBMs over insulin pricing
The Arkansas attorney general has filed a lawsuit accusing several drugmakers and pharmacy benefit managers…
STAT+: A Caribou CAR-T treatment, backed by Nobel-winning science, shows blood-cancer remissions in first data reveal
Caribou Biosciences said Thursday that its CRISPR-edited T-cell therapy induced complete remissions in four of…
STAT+: Pharmalittle: Seagen chief executive is arrested for domestic assault; abortion pill producer has ample supplies
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
STAT+: The FDA eased rules for mental health apps during the pandemic. Now companies are bracing for it to tighten the reins
In April 2020, as the horrors of the pandemic were beginning to unspool, the Food…
STAT+: Advocate Aurora-Atrium’s mammoth merger: experts split on whether federal regulators will challenge the deal
The merger of Advocate Aurora Health and Atrium Health, announced Wednesday, would create one of the…
STAT+: Lawmakers wade into a contentious and long-running battle over orphan drug monopolies
Sparked by an unusual, decade-long fight over a rare disease drug, two U.S. lawmakers have…
STAT+: Police reports detailing Seagen CEO’s arrest raise questions about biotech’s response
Seagen CEO Clay Siegall was arrested and charged with domestic assault after a drunken night…
STAT+: Pharmalittle: Moderna’s new CFO leaves due to probe by former employer; Roche suffers another setback with a cancer drug
Top of the morning to you. The middle of the week is upon us and,…
STAT+: Roche anti-TIGIT cancer immunotherapy fails second clinical trial
Roche said Wednesday that its experimental cancer immunotherapy directed against a target called TIGIT suffered…
STAT+: A new biotech investment firm, headed by a pair of noteworthy VCs, seeks to ‘free the founders’
The way biotech veteran Alexis Borisy and entrepreneur Zach Weinberg see it, the venture capital…
STAT+: Researchers look to deliver ‘unbiased judgment of AI bias’ in medicine
After an explosion of excitement in the potential for machine learning in medicine, cracks in…
STAT+: Why a controversial patent rights waiver could be a ‘missed opportunity’ to tackle the next pandemic
After 18 months, the fate of a contentious proposal before the World Trade Organization to…
STAT+: It took years, but the failure of Northwest Bio’s brain cancer vaccine is now in the open
After years of delays and excuses, Northwest Biotherapeutics finally disclosed on Tuesday the final results…
STAT+: Pharmalittle: Pfizer to pay $11.6 billion for Biohaven; pharmacy chains face a novel trial to determine opioid liability
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Pfizer to buy BioHaven for $11.6 billion, raising hopes for the broader biotech market
Pfizer said Tuesday that it will purchase BioHaven, a maker for migraine drugs, for $11.6…
STAT+: Flagship Pioneering hires lobbyists, a first among biotech venture firms
WASHINGTON — Flagship Pioneering, the venture capital firm behind Moderna, is getting into the Washington…
STAT+: Pharmalittle: Seagen CEO under investigation after alleged domestic violence; Bausch & Lomb settles for a lesser IPO
Good morning, one and all. Damian Garde here, filling in for Ed Silverman on another…